Abstract:Lipid droplets (LD) have long been considered as mere fat drops; however, LD have lately been revealed to be ubiquitous, dynamic and to be present in diverse organelles in which they have a wide range of key functions. Although incompletely understood, the biogenesis of eukaryotic LD initiates with the synthesis of neutral lipids (NL) by enzymes located in the endoplasmic reticulum (ER). The accumulation of NL leads to their segregation into nanometric nuclei which then grow into lenses between the ER leaflets as they are further filled with NL. The lipid composition and interfacial tensions of both ER and the lenses modulate their shape which, together with specific ER proteins, determine the proneness of LD to bud from the ER toward the cytoplasm. The most important function of LD is the buffering of energy. But far beyond this, LD are actively integrated into physiological processes, such as lipid metabolism, control of protein homeostasis, sequestration of toxic lipid metabolic intermediates, protection from stress, and proliferation of tumours. Besides, LD may serve as platforms for pathogen replication and defense. To accomplish these functions, from biogenesis to breakdown, eukaryotic LD have developed mechanisms to travel within the cytoplasm and to establish contact with other organelles. When nutrient deprivation occurs, LD undergo breakdown (lipolysis), which begins with the LD-associated members of the perilipins family PLIN2 and PLIN3 chaperone-mediated autophagy degradation (CMA), a specific type of autophagy that selectively degrades a subset of cytosolic proteins in lysosomes. Indeed, PLINs CMA degradation is a prerequisite for further true lipolysis, which occurs via cytosolic lipases or by lysosome luminal lipases when autophagosomes engulf portions of LD and target them to lysosomes. LD play a crucial role in several pathophysiological processes. Increased accumulation of LD in non-adipose cells is commonly observed in numerous infectious diseases caused by intracellular pathogens including viral, bacterial, and parasite infections, and is gradually recognized as a prominent characteristic in a variety of cancers. This review discusses current evidence related to the modulation of LD biogenesis and breakdown caused by intracellular pathogens and cancer.

Key Factors Governing Initial Stages of Lipid Droplet Formation

Lipid Droplet Nucleation

Dynamical modelling of lipid droplet formation suggests a key function of membrane phospholipids

Phospholipid demixing and the birth of a lipid droplet

Lipid Droplets Big and Small: Basic Mechanisms That Make Them All

Area difference between monolayers facilitates budding of lipid droplets from vesicles

FIT2 proteins and lipid droplet emergence, an interplay between phospholipid synthesis, surface tension, and membrane curvature

Morphologically and Functionally Distinct Lipid Droplet Subpopulations.

Steric Repulsion Counteracts ER-to-Lipid Droplet Protein Movement

Lipid droplets as substrates for protein phase separation

Lipid droplet motility and organelle contacts

CHARMM‐GUI Membrane Builder for Lipid Droplet Modeling and Simulation

Stepwise Biogenesis of Subpopulations of Lipid Droplets in Nitrogen Starved Phaeodactylum tricornutum Cells

The size matters: regulation of lipid storage by lipid droplet dynamics

Imaging lipid droplet fusion and growth.

Dynamics of Vesicle Formation from Lipid Droplet: Mechanism and Controllability

A Lipid Droplet-Associated Protein Involved in Lipid Droplet Biogenesis and Triacylglycerol Accumulation in the Oleaginous Microalga Phaeodactylum Tricornutum

Biogenesis and Breakdown of Lipid Droplets in Pathological Conditions

Acyl-CoA synthetase 3 promotes lipid droplet biogenesis in ER microdomains

Lipid droplet formation is spatiotemporally regulated in oocytes during follicular development in mice

Lipid Domain Order and the Algebra of Morphology